JP2013523841A5 - - Google Patents

Download PDF

Info

Publication number
JP2013523841A5
JP2013523841A5 JP2013504018A JP2013504018A JP2013523841A5 JP 2013523841 A5 JP2013523841 A5 JP 2013523841A5 JP 2013504018 A JP2013504018 A JP 2013504018A JP 2013504018 A JP2013504018 A JP 2013504018A JP 2013523841 A5 JP2013523841 A5 JP 2013523841A5
Authority
JP
Japan
Prior art keywords
cord blood
umbilical cord
stem cell
human umbilical
blood stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013504018A
Other languages
English (en)
Japanese (ja)
Other versions
JP6165627B2 (ja
JP2013523841A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/031953 external-priority patent/WO2011127470A1/en
Publication of JP2013523841A publication Critical patent/JP2013523841A/ja
Publication of JP2013523841A5 publication Critical patent/JP2013523841A5/ja
Application granted granted Critical
Publication of JP6165627B2 publication Critical patent/JP6165627B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013504018A 2010-04-09 2011-04-11 Hlaの適合なしに造血機能を提供するための組成物および方法 Active JP6165627B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32254410P 2010-04-09 2010-04-09
US61/322,544 2010-04-09
PCT/US2011/031953 WO2011127470A1 (en) 2010-04-09 2011-04-11 Compositions and methods for providing hematopoietic function without hla matching

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017056141A Division JP6853081B2 (ja) 2010-04-09 2017-03-22 Hlaの適合なしに造血機能を提供するための組成物および方法

Publications (3)

Publication Number Publication Date
JP2013523841A JP2013523841A (ja) 2013-06-17
JP2013523841A5 true JP2013523841A5 (https=) 2015-05-21
JP6165627B2 JP6165627B2 (ja) 2017-07-19

Family

ID=44120970

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2013504018A Active JP6165627B2 (ja) 2010-04-09 2011-04-11 Hlaの適合なしに造血機能を提供するための組成物および方法
JP2017056141A Active JP6853081B2 (ja) 2010-04-09 2017-03-22 Hlaの適合なしに造血機能を提供するための組成物および方法
JP2019051186A Active JP6998911B2 (ja) 2010-04-09 2019-03-19 Hlaの適合なしに造血機能を提供するための組成物
JP2021066078A Pending JP2021105045A (ja) 2010-04-09 2021-04-08 Hlaの適合なしに造血機能を提供するための組成物および方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2017056141A Active JP6853081B2 (ja) 2010-04-09 2017-03-22 Hlaの適合なしに造血機能を提供するための組成物および方法
JP2019051186A Active JP6998911B2 (ja) 2010-04-09 2019-03-19 Hlaの適合なしに造血機能を提供するための組成物
JP2021066078A Pending JP2021105045A (ja) 2010-04-09 2021-04-08 Hlaの適合なしに造血機能を提供するための組成物および方法

Country Status (5)

Country Link
US (4) US20130095079A1 (https=)
EP (3) EP2555782A1 (https=)
JP (4) JP6165627B2 (https=)
CA (1) CA2795627C (https=)
WO (1) WO2011127470A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2788476B1 (en) 2011-12-08 2019-05-22 Fred Hutchinson Cancer Research Center Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
EP2943566A1 (en) 2013-01-08 2015-11-18 Fred Hutchinson Cancer Research Center Compositions and methods for expansion of embryonic hematopoietic stem cells
CN105873952A (zh) 2013-10-31 2016-08-17 弗莱德哈钦森癌症研究中心 经修饰的造血干细胞/祖细胞和非t效应细胞及其用途
WO2015120197A1 (en) * 2014-02-05 2015-08-13 Regents Of The University Of California Rna editing biomarkers for diagnosis, pharmacological screening and prognostication in cancer
FR3026744B1 (fr) 2014-10-06 2024-04-19 Hopitaux Paris Assist Publique Methode de generation de progeniteurs de cellules t
CN115777690A (zh) * 2014-11-14 2023-03-14 日本赤十字社 脐带血以及末梢血的冻结保存方法以及冻结保存用溶液
JP2016104711A (ja) * 2014-11-21 2016-06-09 国立大学法人 東京大学 造血幹細胞移植を補助することに用いるための医薬組成物およびその製造方法
WO2016118780A1 (en) 2015-01-21 2016-07-28 Fred Hutchinson Cancer Research Center Point-of-care and/or portable platform for gene therapy
US20180015125A1 (en) * 2015-03-23 2018-01-18 Pluristem Ltd. Use of adherent stromal cells for enhancing hematopoiesis in a subject in need thereof
EP3288569A4 (en) 2015-04-29 2018-12-19 Fred Hutchinson Cancer Research Center Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
EP3288570A4 (en) 2015-04-29 2018-11-21 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof
RU2747728C2 (ru) * 2015-12-04 2021-05-13 Фред Хатчинсон Кэнсер Рисерч Сентер Применение размноженных популяций гематопоэтических стволовых клеток/клеток-предшественников
ES2931530T3 (es) 2017-02-13 2022-12-30 Hopitaux Paris Assist Publique Método para generar progenitores de células T
EP4417210A1 (en) * 2017-03-15 2024-08-21 Orca Biosystems, Inc. Compositions and methods for hematopoietic stem cell transplants
WO2020056170A1 (en) 2018-09-12 2020-03-19 Fred Hutchinson Cancer Research Center Reducing cd33 expression to selectively protect therapeutic cells
EP3741842A4 (en) * 2018-09-27 2021-04-21 TERUMO Kabushiki Kaisha CELL CRYOPRESERVATION METHOD
MX2021014039A (es) * 2019-05-17 2022-02-11 Deverra Therapeutics Inc Composiciones y métodos para mejorar resultados de tratamiento para pacientes que tienen neoplasias malignas hematológicas usando un producto de células madre expandidas.
JP2022542321A (ja) * 2019-07-29 2022-09-30 デヴェラ セラピューティクス インコーポレイテッド 免疫療法のためのnk細胞組成物および調製物ならびにそれらの製造のための方法
WO2021108769A1 (en) * 2019-11-27 2021-06-03 Deverra Therapeutics Inc. Compositions and methods for culturing hematopoietic stem and progenitor cells
AU2021245671A1 (en) * 2020-03-31 2022-10-20 Cell Exosome Therapeutics Inc. Cell preservation method
WO2022005462A1 (en) * 2020-06-30 2022-01-06 Tr1X, Inc. Poly-donor cd4+ t cells expressing il-10 and uses thereof
CN114187965A (zh) * 2021-12-09 2022-03-15 中国医学科学院血液病医院(中国医学科学院血液学研究所) 一种人骨髓造血干/祖细胞的单细胞转录组图谱及构建方法
US20250135039A1 (en) 2022-02-07 2025-05-01 Ensoma, Inc. Inhibitor-resistant mgmt modifications and modification of mgmt-encoding nucleic acids

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753357A (en) 1970-12-14 1973-08-21 Ovitron Res Corp Method and apparatus for the preservation of cells and tissues
US4199022A (en) 1978-12-08 1980-04-22 The United States Of America As Represented By The Department Of Energy Method of freezing living cells and tissues with improved subsequent survival
US4559298A (en) 1982-11-23 1985-12-17 American National Red Cross Cryopreservation of biological materials in a non-frozen or vitreous state
US5004681B1 (en) 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
IL101728A (en) 1991-05-03 2007-08-19 Univ Yale Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them
US5856441A (en) 1991-05-03 1999-01-05 Yale University Serrate fragments and derivatives
IE20030749A1 (en) 1991-05-03 2003-11-12 Indiana University Foundation Human notch and delta binding domains in torporythmic proteins, and methods based thereon
WO1993012141A1 (en) 1991-12-11 1993-06-24 Yale University Nucleotide and protein sequences of the serrate gene and methods based thereon
US5869282A (en) 1991-12-11 1999-02-09 Imperial Cancer Research Technology, Ltd. Nucleotide and protein sequences of the serrate gene and methods based thereon
DE69638023D1 (de) 1995-06-28 2009-10-22 Univ Yale Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden
US5780300A (en) 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
WO2002059285A1 (en) * 2000-10-27 2002-08-01 Fred Hutchinson Cancer Research Center Methods for immortalizing cells
AU2003219966A1 (en) * 2002-03-05 2003-09-22 Daniel D. Richard Dual blood donation plus method
WO2004071283A2 (en) * 2003-02-13 2004-08-26 Anthrogenesis Corporation Use of umbilical cord blood to treat individuals having a disease, disorder or condition
JP2005102656A (ja) * 2003-10-02 2005-04-21 Toray Ind Inc 細胞培養器具およびそれを用いた細胞製剤の製造方法
CN1961283A (zh) * 2004-03-26 2007-05-09 细胞基因公司 建立干细胞库的系统和方法
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
ZA200704252B (en) 2004-10-25 2009-09-30 Cellerant Therapeutics Inc Methods of expanding myeloid cell populations and uses thereof
EP1906729B1 (en) * 2005-06-02 2012-03-28 Stemcyte, Inc. Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use
CN101421393B (zh) 2006-02-14 2013-08-14 塞勒兰特治疗公司 提高造血干细胞植入的方法和组合物

Similar Documents

Publication Publication Date Title
JP2013523841A5 (https=)
JP2013523842A5 (https=)
JP2019214620A5 (https=)
McKenna et al. Umbilical cord blood: current status & promise for the future
CU24495B1 (es) Compuestos que expanden las células hematopoyéticas y método ex vivo para expandir las células hematopoyéticas
Sakaguchi et al. Incidence, clinical features, and risk factors of idiopathic pneumonia syndrome following hematopoietic stem cell transplantation in children
Yoder Cord blood banking and transplantation: advances and controversies
Koh et al. Haploidentical hematopoietic cell transplantation
Dwyer et al. Cardiomyocytes in hypoxia: cellular responses and implications for cell-based cardiac regenerative therapies
Issa et al. The potential role for regulatory T-cell therapy in vascularized composite allograft transplantation
Stanevsky et al. Double umbilical cord blood transplant: more than a cell dose?
Rényi-Vámos et al. Launching the Hungarian lung transplantation program
JP2018537440A5 (https=)
Tejeda-Mora et al. Endothelial Cell Replacement of Human Veins, Modeling Vascular Repair and Endothelial Cell Chimerism
Rengel Kidney Transplantation with Grafts from Non–Heart-Beating Donors
Brännström et al. Uterus transplantation: how far away from human trials?
Bisigniano et al. Analysis of mortality while on waiting list for kidney transplant in adults in Argentina 2005–2009
van Gorkom et al. Real‐world experience: Introduction of T cell replete haploidentical transplantations in a single center
JP2016062514A (ja) iPS細胞因子及びまたは各種幹細胞、T細胞、樹状細胞等から解析した遺伝子データ及びまたは細胞周期予測データを再生医療に応用することを特徴とする社会保障システム。
Calne Organ transplantation has come of age
Arif et al. Senescent profile of cryopreserved adipose mesenchymal stem cells after multiple passages
Maalaoui Characterization of the UM171-Graft: Dissecting the lymphoid lineage potential of the UM171-Graft
Broxmeyer Stem and progenitor cells isolated from cord blood
Huang et al. A Single Center's Experience with Donation of Facial Allografts for Transplantation
Fabien et al. An Emperical Evidence on Customers’ Perception of Bank Services’ Quality in Cameroon